TMCnet News
Catabasis Pharmaceuticals Management to Present at October Investor ConferencesCAMBRIDGE, Mass. --(Business Wire)-- Catabasis Pharmaceuticals, Inc., a clinical stage drug development company built on a pathway pharmacology technology platform, today announced that management will present an overview of Catabasis and its lead drug development programs at the following investor conferences in October:
Catabasis Pharmaceuticals is leveraging its pathway pharmacology drug development platform to bring important medicines to patients with severe lipid disorders and rare diseases. The Company's mission is to address difficult-to-treat diseases through the simultaneous modulation of multiple targets in a disease pathway. For more information on our technology and pipeline of drug candidates, please visit www.catabasis.com.
|